Pilot Study Explores Dapagliflozin Use in Type 1 DiabetesPilot Study Explores Dapagliflozin Use in Type 1 Diabetes

Already approved for use in type 2 diabetes, the SGLT2 inhibitor dapagliflozin is tested in a pilot trial in patients with type 1 diabetes along with insulin therapy. Medscape Medical News

Source: Medscape Diabetes Headlines - October 8, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news